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Abstract:

Caves are stable environments that favour the development of several microorganisms.
The aspergilli represent a large number of species isolated from caves including strains
capable of causing serious invasive opportunistic infections in humans. Considering that
caves may harbour resistant strains to many antibiotics, investigation on the response of
opportunistic aspergilli, isolated from pristine and tourist caves to antifungal agents and the
mechanisms involved in resistance might be clinically relevant. A total of 32 strains of the
species Aspergillus candidus, A. flavus, A. fumigatus, A. niger, A. tamarii, and A. terreus
were isolated from caves in the iron quadrangle in Brazil. The strains were tested for their
susceptibility to amphotericin B (AMB), itraconazole, voriconazole and terbinafine. One strain
was analysed for the mechanism involved in the AMB-resistance, i.e., ergosterol content,
lipid peroxidation and enzymatic activity of the antioxidant system. Terbinafine minimum
inhibitory concentrations (MICs) ranged between 0.003 and 1.0 µg/mL; voriconazole MICs
ranged between 2.0 and >16.0 µg/mL; itraconazole MICs ranged between 0.25 and 8.0
µg/mL and amphotericin B MICs ranged between 0.03 and 4.0 µg/mL. The AMB-resistant
strain of A. flavus was detected with MIC value of 4 µg/mL. Resistance to AMB relied on
higher ergosterol levels and increased enzymatic activity of the peroxidase and superoxidedismutase, with lower lipid peroxidation. These results enhance the knowledge of natural
antifungal resistance in the subterranean ecosystem, and broaden the knowledge about the
subterranean microbiota.
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INTRODUCTION
Caves are unique ecosystems with environmental
characteristics that may favour the growth of several
microorganisms (Poulson & White, 1969; Culver
& White, 2005). The genus Aspergillus has often
been reported in subterranean environments and
represents many of the identified fungal species
isolated from caves (Vanderwolf et al., 2013),
including several species capable of causing serious
invasive opportunistic infections in humans (Taylor et
al., 2013; Vanderwolf et al., 2013; Taylor et al., 2014).
The species Aspergillus fumigatus (Perfect et al., 2001),
A. flavus (Walsh et al., 2008), A. terreus (Iwen et al.,
1998; Mokaddas et al., 2010), and A. niger (Person et
*maresend@icb.ufmg.br

al., 2010) are the main causative agents of invasive
pulmonary aspergillosis (IPA) in humans (Walsh et
al., 2008; Kousha et al., 2011). Although IPA occurs
mainly among immunocompromised individuals,
cases of pulmonary infection by aspergilli have been
reported in immunocompetent individuals (Person
et al., 2010; Kousha et al., 2011). The polyenes and
azoles are the agents most commonly used in the
treatment of IPA. Resistance to these drugs have
been increasingly reported (Ghannoum & Rice,
1999; Singh, 2001; Kousha et al., 2011) raising the
possibility of natural acquired resistance (Loeffler &
Stevens, 2003).
Most caves are considered extreme environments
due to their oligotrophic conditions. Normally, caveThe author’s rights are protected under a Creative Commons AttributionNonCommercial 4.0 International (CC BY-NC 4.0) license.
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dwelling organisms adapt to this nutrient limitation
in order to survive and colonize the ecosystem (Culver
& White, 2005). Among cave microorganisms, this
adaptation may occur at the morphological and/or
physiological level. Competition for substrate among
sympatric fungal species normally leads to production
of metabolites capable of eliminating competition,
such as antibiotics, acidifying metabolites, and toxins
(Griffin, 1994). Antibiotic resistance among cave
isolated bacteria has been described as result of genetic
background and selective forces involved in various
ecological interactions in the subterranean environment
(Bhullar et al., 2012). Fungi may also be undergoing
the same process, which may cause natural selection
of opportunistic and pathogenic strains resistant to
currently used antifungal drugs. The fact that several
caves have large mats of actinomycetes competing with
fungi for substrates and that the most potent antifungal
drug (amphotericin B) used in treatment of IPA was
firstly obtained from actinomycetes (Streptomyces
nodosus) (Svahn et al., 2015), reinforces this hypothesis.
Thus, prospective studies on the effect of antifungal
drugs against strains colonizing caves are relevant.
Considering that IPA may represent a silent emerging
risk to cave visitors, and that caves may harbour
strains resistant to antifungals, we conducted a
pioneer investigation on the response of opportunistic
Aspergillus spp., isolated from pristine and tourist
caves, to the most commonly used antifungal agents
(amphotericin B, itraconazole, voriconazole and
terbinafine) and the mechanisms involved in the
resistance to AMB.

MATERIALS AND METHODS
Study site
The strains used in this study were obtained from
eight different caves located in the Iron Quadrangle
(Quadrilátero Ferrífero, Minas Gerais state, Brazil).
This region is economically important due to their
proximity with the state capital, urban/rural areas
and sites with large mining activities (mainly metal
ores). Furthermore, cave visitation has increased in
past years. The strains used in this study were isolated
from seven iron ore caves: Rola Moça II (Brumadinho,
Minas Gerais, Brazil- 20°03’38.5” S / 44°00’30.4” W),
Rola Moça III (Belo Horizonte, Minas Gerais, Brazil20°02’38.1” S / 44°00’23.2” W), Macumba (Sabará,
Minas Gerais, Brazil- 19°40’01.1” S / 43°40’30.1” W),
Romeiros (Sabará, Minas Gerais, Brazil- 19°49’00.3” S /
43°40’35.9” W), Bloco Abatido (Sabará, Minas Gerais,
Brazil- 19°49’02” S / 43°40’50” W), Cascalhinho (Caeté,
Minas Gerais, Brazil- 19°48’59.1” S / 43°40’28.7” W),
Eremita (Sabará, Minas Gerais, Brazil- 19°49’19.5”
S / 43°40’49.5” W) and one dolomitic cave, Nossa
Senhora da Conceição da Lapa (Ouro Preto, Minas
Gerais, Brazil- 20°18’18.4” S / 43°28’20.6” W) (Fig. 1).
Aspergillus strains
Five species of aspergilli were selected due to their
association as causative agents of IPA in humans. A
total of 33 strains of the species Aspergillus candidus
(Taylor et al., 2014), A. flavus (Ghannoum & Rice,

Fig. 1. Location of the eight caves studied in the Iron Quadrangle (Minas
Gerais State, Brazil): Rola Moça II Cave, Rola Moça III Cave, Macumba
Cave, Romeiros Cave, Cascalhinho Cave, Eremita Cave, Bloco Abatido
Cave, and Nossa Senhora da Conceição da Lapa Cave. State capital
Belo Horizonte is also indicated.

1999), A. fumigatus (Perfect et al., 2001), A. niger
(Perfect et al., 2001), A. terreus (Culver & White,
2005), and A. tamarii (Culver & White, 2005) were
used that had previously been isolated from the
caves during a mycological inventory performed in
the period between the years 2010/2013. Strains
were sampled from air by the settle plate technique
with a 20-minute exposure on Dichloram Rose
Bengal Cloramphenicol Agar (DRBC, Acumedia
Laboratories, Lansing, MI USA) and Sabouraud
Dextrose Agar (SDA, Difco Laboratories, Detroit, MI
USA) with cloramphenicol (0.1%), and from sediment
by a 10-fold serial dilution on DRBC (Acumedia).
These strains are currently deposited in the
mycological collection of cave fungi in the Mycological
Laboratory of the Federal University of Minas Gerais
(Laboratório de Micologia da Universidade Federal
de Minas Gerais-LM/UFMG, Belo Horizonte, Minas
Gerais, Brazil).
Identification of species was confirmed through
analysis
of
macro
and
micromorphological
characteristics in solid media, following standard
taxonomic keys and recently published works
(Klich, 2002; Domsch et al., 2007). Two media were
used for each strain and at different temperature
regimens: Czapeck Yeast Extract Agar (CYA, Labsynth,
Diadema, SP Brazil) at 25°C/7d; CYA (Labsynth)
at 37°C/7d; and Malt Extract Agar (MEA, Difco) at
25°C/7d (Klich, 2002).
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Thermotolerance assay
Before initiating the in vitro susceptibility assays, a
preliminary triage was performed to exclude strains
with negative growth at 37°C. The media used in this
procedure were SDA (Difco) (25°C and 37°C for 7days)
and Brain Heart Infusion Agar (BHIA, Acumedia) (37°C
for 7 days). The strains presenting positive growth at
37°C were submitted to in vitro drug susceptibility
assays to amphotericin B (AMB), itraconazole (ITC),
voriconazole (VCZ) and terbinafine (TBF).
Minimum inhibitory concentration
(MIC) determination
The minimum inhibitory concentration (MIC) for
AMB (Sigma-Aldrich, St. Louis, Missouri, USA),
ITC (Sigma-Aldrich), VCZ (Sigma-Aldrich) and TBF
(Sigma-Aldrich) were determined by the antifungal
microdilution susceptibility standard test proposed
by the CLSI M38-A2 (CLSI, 2008). The inoculum
was prepared in sterile saline solution and the
transmittance of suspension was adjusted to 68-70%
(530 nm) as standard protocol for filamentous fungi
(M38 from CLSI). This suspension was diluted in RPMI1640 buffered with MOPS (Sigma-Aldrich) medium to
achieve 1.0 x 103 to 5.0 x 103 CFU/mL (colony forming
units per mL). The drugs were dissolved in 100%
dimethylsulphoxide according to the protocol of CLSI
at 1.0 mg/mL. Final concentrations ranged from 0.03
to 16 µg/mL for AMB, ITC and VCZ and ranged from
0.00195 to 1.0 µg/mL for TBF.
In each case, a volume of 100 µL of the inoculum
suspension was transferred to sterile flat-bottom 96
well plates containing100 µL of each of the antifungal.
Control on RPMI-1640 was also performed (control
growth). The plates were incubated at 37°C for 72h.
All tests were performed in duplicate (for each strain).
Ergosterol quantification
Amphotericin B resistant (AmB-R) and amphotericin
B susceptible (AmB-S) strains were cultured
(37°C/72h) on SDA supplemented with AmB (1/2 MIC
concentration) and approximately 10.0 mg of the
fungal cell mass were transferred to polypropylene
tubes. A growth control was also performed. For the
extraction of lipids, 3 mL of ethanolic solution of
potassium hydroxide 25% were added to each cell
mass and agitated for one minute. The tubes were
incubated in a water bath at 85°C for one hour and
cooled at room temperature. A mixture of 1 mL of
sterile water and 3 mL of n-heptane (Sigma-Aldrich)
was added, followed by agitation in a vortex for three
minutes. The supernatant was removed and the
reading was performed in spectrophotometer at 282
nm and 230 nm. A calibration curve with standard
ergosterol (Sigma-Aldrich) was constructed and used
to calculate the amount of ergosterol. The results were
expressed as percentage of ergosterol in comparison
with the growth control and represent the means of
three independent experiments.
Lipid peroxidation assay
Aspergillus strains were cultured (37°C/72h) on
SDA supplemented with amphotericin B (1/2 MIC
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concentration) and hydrogen peroxide (HP) 1%
as positive control. The products of the lipid
peroxidation were measured as thiobarbituric acidreactive substances (TBARS). The pellet was frozen
and homogenized with 1000 µL in ice-cold 1.1%
phosphoric acid using water as diluent (v/v). Four
hundred µL of the homogenate was mixed with 400 µL
of 1% thiobarbituric acid (Sigma-Aldrich) prepared
in 50 mM NaOH containing 0.1 mM butylated
hydroxytoluene and 200 µL of 7% phosphoric acid (all
the solutions were kept on ice during manipulation).
Subsequently, samples (pH 1.5) were heated for
60 minutes at 98°C and 1500 µL of butanol were added.
The mixture was mixed vigorously using a vortex and
centrifuged for five minutes at 2000 g. The organic layer
was transferred and the absorbance was measured
at 532 nm (Termo Scientific Multiscan spectrum,
Termo Ficher Scientific). The thiobarbituric acid
solution was replaced by 3 mM HCl in the controls.
TBARS values were calculated using the extinction
coefficient of 156 mM/cm and represent the means
of three independent experiments. The results were
expressed as the ratio between TBARS from cells
treated with AMB or HP and the values registered in
the control ± SE.
Enzymatic activity of the antioxidant system
Prior to the tests, a cell-free extract from susceptible
and resistant strains of A. flavus were cultured
(37°C/72 h) on SDA supplemented with AMB (1/2 MIC
concentration) and on positive control with HP 1%
according to the method described by Ferreira et al.
(2013). Soluble protein was determined using the
Bradford test using a standard curve of bovine serum
albumin.
Peroxidase (PER) activity
The PER activity was analyzed according with
method previously used (Ferreira et al., 2013) and
measured in a system containing H2O2 and guaiacol
as substrate. Values were obtained by monitoring
the absorbance changes at λ = 470 nm using molar
extinction coefficient value of 26.61 M-1cm-1 for the
product tetra guaiacol formed by the enzymatic
reaction. The data were calculated in nmols/min
mg-1 of protein and represent the means of three
independent experiments. The results were expressed
as the ratio of nmols/min mg-1 of protein from cells
treated with AMB or HP to the nmols/min mg-1 of
protein from growth control ± SE.
Superoxide dismutase (SOD) activity
The SOD activity was measured by the inhibition
of pyrogallol autoxidation as described previously
(Ferreira et al., 2013). In the test samples, 100 µL
of cell-free extract was added to pyrogallol and the
inhibition of autoxidation was monitored every 30s for
three minutes at a wavelength of 420 nm. The unit
of SOD was considered as pyrogallol autoxidation per
200 µL calculated as follows:
Unit of SOD mL-1 of sample = (A-B)/A x 50 x 100 x 0.6
(dilution factor) where A is the difference in absorbance
per minute in the control and B the difference in
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absorbance per minute in the test samples. Data was
calculated in units/mg of protein and represent the
means of three independent experiments. The results
were expressed as the ratio between the units/mg of
protein extracted from cells treated with AMB or HP
and the units/mg of protein from growth control ± SE.
Statistical analysis
A Student’s two-tailed t test and a one-way analysis
of variance (ANOVA) with the Bonferroni multiplecomparison were used to compare the differences
among groups. Significance was determined by values
of p<0.05 in all experiments. The program used was

GraphPad Prism version 5.0 for Windows (GraphPad
Software, San Diego, CA, USA).

RESULTS
A total of 33 strains of Aspergillus spp. were isolated
in this study (Table 1). Thirty-two were able to grow at
37°C. The results of growth and brief characterization
of their habitat are shown in Table 1.
In vitro susceptibility data
The MICs for azoles against the Aspergillus strains
ranging between 2 µg/mL and >16 µg/mL to VCZ, and

Table 1. Aspergillus strains isolated from caves in the Iron Quadrangle in Minas Gerais state, Brazil Growth rate of Aspergillus spp. on Sabouraud
Dextrose Agar (25°C and 37°C) and Brain Heart Infusion (37°C) after seven days of incubation.
Taxon
(strain no.)

Growth
(mm)
SDA
25°C

Habitat
BHI

37°C

Substrate

Zone of
isolation

Cave

37°C

Aspergillus candidus
UFMGLMCC03

17

8

3

Air

Aphotic

RM 3

UFMGLMCC028

20

12

11

Sediment

Disphotic

RM 3

UFMGLMCC011

20

5

3

Sediment

Disphotic

Gruta do Bloco Abatido

UFMGLMCC015

19

18

15

Sediment

Aphotic

Gruta do Cascalhinho

UFMGLMCC014

22

-

-

Air

Disphotic

RM3
Gruta do Eremita

Aspergillus flavus
UFMGLMCC04

60

51

50

Air

Disphotic

UFMGLMCC05

62

50

50

Sediment

Disphotic

RM3

UFMGLMCC06

53

47

45

Sediment

Disphotic

Gruta da Macumba

UFMGLMCC09

62

44

49

Air

Photic

Gruta dos Romeiros

UFMGLMCC019

61

60

60

Air

Disphotic

Gruta N. S. Conceição

UFMGLMCC021

59

55

52

Sediment

Aphotic

Gruta N. S. Conceição

UFMGLMCC024

52

49

44

Sediment

Disphotic

Gruta do Cascalhinho

UFMGLMCC025

63

62

63

Sediment

Disphotic

Gruta RM2

UFMGLMCC026

70

66

65

Sediment

Photic

Gruta Eremita

UFMGLMCC027

58

55

59

Sediment

Disphotic

Gruta RM3

UFMGLMCC030

69

58

59

Sediment

Aphotic

Gruta N. S. Conceição

UFMGLMCC033

44

49

50

Vegetal debris

Disphotic

Gruta dos Romeiros

UFMGLMCC01

61

59

62

Air

Aphotic

RM 3

UFMGLMCC02

64

60

58

Sediment

Disphotic

Gruta N. S. Conceição

UFMGLMCC07

57

56

59

Sediment

Aphotic

Gruta do Bloco Abatido

UFMGLMCC013

68

62

59

Sediment

Disphotic

Gruta RM3

UFMGLMCC010

66

69

67

Sediment

Disphotic

Gruta do Cascalhinho

UFMGLMCC022

64

60

61

Sediment

Disphotic

Gruta N. S. Conceição

UFMGLMCC016

70

68

68

Sediment

Disphotic

RM3

UFMGLMCC017

54

52

53

Sediment

Disphotic

Gruta RM2

Aspergillus fumigatus

Aspergillus niger

UFMGLMCC018

71

64

61

Air

Disphotic

Gruta do Eremita

UFMGLMCC023

69

68

68

Air

Disphotic

Gruta do Eremita

UFMGLMCC029

57

49

52

Sediment

Aphotic

Gruta N. S. Conceição

UFMGLMCC034

62

60

62

Sediment

Disphotic

Gruta da Macumba

UFMGLMCC012

49

36

39

Sediment

Aphotic

Gruta N. S. Conceição

UFMGLMCC020

53

53

51

Sediment

Disphotic

Gruta dos Romeiros

UFMGLMCC031

59

54

50

Sediment

Disphotic

Gruta do Bloco Abatido

UFMGLMCC032

62

59

55

Sediment

Disphotic

Gruta RM2

Aspergillus tamarii

Aspergillus terreus
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between 0.25 and 8 µg/mL to ITC. Itraconazole had
lower MIC values, with at least 50% of the Aspergillus
strains inhibited at 0.5 µg/mL. The lower ITC MICs were
observed against A. candidus and A. terreus (Table 2).
Amphotericin B had low MICs against the
Aspergillus species tested, being the values below
2 µg/mL for 29 strains. However the AMB MIC for
three strains were 2 µg/mL (A. flavus, A. niger, and
A. terreus) e.g., breakpoint determined by the CLSI;
and 4 µg/mL for one strain of A. flavus. The mean
value for AMB MIC50 was 0.5 µg/mL against A.
candidus, A. flavus, A. fumigatus, A. tamarii, and A.
terreus. For A. niger this value was lower with MIC
of 0.25 µg/mL for at least fifty per cent of strains.
The strain UFMGLMCC05 (A. flavus) was classified
as amphotericin B-resistant (AmB-R) and submitted
to further analysis of resistance mechanism. Finally,
TBF MIC values ranged between 0.003 and 1 µg/mL
(Table 2).
Amphotericin B-resistant versus
susceptible A. flavus
AmB-R A. flavus (UFMGLMCC05) was collected from
the sediment in the disphotic zone of RM3 cave where
whitish/yellowish mats of actinomycetes (including
Streptomyces spp., unpublished data) covered the
sediment. The AmB-S used for comparison was
obtained from our mycological collection and was
firstly isolated from a highly visited show cave with
no visible growth of actinomycetes (Aspergillus
flavus UFMGLMCC103, Maquiné Cave/Cordisburgo,
MG, Brazil). We have selected this AmB-S strain to
eliminate possible local adaptive effects.
The AmB-R has higher levels of ergosterol than and
AmB-S A. flavus in control media (p<0.05) and when
exposed to AMB (p<0.05) (Fig. 2). Furthermore, the
lipid peroxidation results (expresses as TBARS levels)
showed that the AmB-R strain was less susceptible
to oxidative stress caused by AMB and HP (p<0.05)
(Fig. 3). The investigation of enzymatic activities of
PER and SOD in response to oxidative stress showed
that PER activity was similar between the AmB-S and
AmB-R when treated with AMB. When treated with
HP, AmB-S had lower PER activity compared with
a large increase in AmB-R strain (Fig. 3) (p<0.05).
On the other hand, the SOD activity was higher
(p<0.05) in the AmB-R strain exposed to the drug and
HP (Fig. 3).

DISCUSSION
Resistance to antibiotic compounds involve several
mechanisms aimed at reducing drug content in the
cell, decreasing interaction between the drug and
its target, and metabolic modifications to counter
balance the lethal effect of the drug (Vandeputte et
al., 2012). It is evident that all mechanisms involved
in drug-resistance result from an adaptive response
and fitness enhancement (Anderson, 2005). This
interaction is commonly triggered by contact with
the drug due to soil/water contamination (clinical
or agricultural use) or ecological interactions with
organisms producing these antifungal agents in the
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Table 2. Minimal Inhibitory Concentration (MIC) values (µg/mL) for
amphotericin B (AMB), itraconazole (ITC), voriconazole (VCZ) and
terbinafine (TBF) against thirty-two Aspergillus strains isolated from
caves in Minas Gerais (Brazil).
Taxon
(strain no.)

MIC (µg/mL )
AMB

ITC

VCZ

TBF

1

0.5

8

0.0625

Aspergillus candidus
UFMGLMCC03
UFMGLMCC028

0.03

0.25

4

0.0625

UFMGLMCC11

0.5

0.5

4

0.125

UFMGLMCC15

0.5

0.5

4

0.003

0.5

0.5

4

0.0625

UFMGLMCC04

0.5

4

4

0.125

MIC 50 (µg/mL )

a

Aspergillus flavus
UFMGLMCC05

4

0.25

8

0.0625

UFMGLMCC06

0.5

4

>16b

0.0625

UFMGLMCC09

1

0.5

8

0.125
0.0312

b

UFMGLMCC019

0.5

4

4

UFMGLMCC021

0.5

0.5

8

UFMGLMCC024

0.5

1

>16

UFMGLMCC025

1

0.5

8

1b

UFMGLMCC026

1

0.5

8

0.0625

UFMGLMCC027

0.25

1

4

0.0625

UFMGLMCC030

2

4

4

0.001

UFMGLMCC033

1

8

16b

0.5

MIC 50 (µg/mL )

0.5

1

8

0.0625

UFMGLMCC01

1

4

8

1

UFMGLMCC02

0.5

1

2

0.0625

UFMGLMCC07

1

4

4

0.125

UFMGLMCC013

0.5

0.5

4

0.0625

UFMGLMCC010

0.25

0.5

4

0.0625

UFMGLMCC022

0.5

4

8

0.003

MIC 50 (µg/mL )

0.5

1

4

0.0625

UFMGLMCC016

0.25

8

4

0.0625

UFMGLMCC017

0.25

8

4

0.001

UFMGLMCC018

0.25

8

8

0.0625

UFMGLMCC023

0.5

0.5

8

0.003

UFMGLMCC029

0.0125

0.25

8

0.0625

0.0625
b

0.5

Aspergillus fumigatus

Aspergillus niger

UFMGLMCC034

2

4

8

0.0625

MIC 50 (µg/mL )

0.25

4

8

0.0625

UFMGLMCC012

0.5

1

4

0.03

UFMGLMCC020

1

1

8

0.03

MIC 50 (µg/mL )

0.5

1

4

0.03

Aspergillus tamarii

Aspergillus terreus
UFMGLMCC031

2

0.5

4

0.25

UFMGLMCC032

1

0.25

4

0.125

MIC 50 (µg/mL )

1

0.25

4

0.125

a

MIC50: MIC value which inhibits 50% of the strains

environment (Anderson, 2005; Vandeputte et al., 2012).
Although recent studies have focused in investigating
drug resistance and mechanisms involved among
cave isolated bacteria (Bhullar et al., 2012), this is the
first study that aimed at investigating drug resistance
among cave isolated filamentous fungi.
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Fig. 2. Effect of amphotericin B (AMB) in susceptible and resistant
Aspergillus flavus strains. Results are expressed in mg/mL. Data are
represented as the mean + SEM of two independent experiments
in triplicate assays. Statistically significant differences between the
treatment and the control (no drug) are indicated with connect lines
and between susceptible and resistant strains are indicated with
asterisks (p<0.05). Amb-S = susceptible strain to amphotericin B;
Amb-R = resistant strain to amphotericin B.

Fig. 3. Resistant cells are less susceptible to oxidative burst. (A) Lipid peroxidation (TBARs, thiobarbituric acid-reactive substances) (B) PER
(peroxidase) (C) SOD (superoxide dismutase) activities after treatment with amphotericin B (AMB) and hydrogen peroxide (HP). Results are
expressed as the ratio of the treatment to the control. Statistical differences are represented by the connect line (p < 0.05). Data represent the
mean ± S.E. of two independent experiments consisting of triplicate assays. Amb-S = susceptible strain to amphotericin B; Amb-R = resistant
strain to amphotericin B.

Terbinafine had the lowest MICs among the cave
isolated fungi and the lower MICs with no resistant
strains. Although TBF is not usually used in treatment
of invasive pulmonary aspergillosis (Kousha et al.,
1999), its use combined with AMB and azoles has
been investigated (Ryder & Leitner, 2001; Mosquera
et al., 2002; Cuenca-Estrella, 2004; Fernandez et
al., 2015). Additive and synergistic relations have
been reported between triazoles and TBF, as well as
sinergism between AMB and TBF (Singh & Paterson,
2005). Additionally the AmB-resistant A. flavus had
low TBF MICs, which is a result that deserves further
evaluation aimed at combined use of drugs.
Our results clearly showed that, among the azoles,
ITC had lower MIC values against the strains tested

when compared with VCZ. Döring and colleagues
(2014) reported similar result with ITC in clinical
strains obtained from paediatric patients. Indeed,
it is important to highlight that our samples came
from iron-rich sediment, which could be inducing
resistance mechanisms against azoles as already
observed in clinical and in vivo assays (Prasad et al.,
2006; Craven et al., 2007; Zarember et al., 2009;
Chowdhary et al., 2013; Hosogaya et al., 2013).
Hosogaya and colleagues (2013) showed a strong
positive relation between iron concentrations and
resistance to azoles in Candida glabrata. The authors
showed that the protein Dap1 is indirectly involved
in the ergosterol biosynthesis and their results
suggested heme binding by Dap1 is crucial for Erg11
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activity and ergosterol biosynthesis, thereby being
required for azole tolerance. Similar relation between
iron depletion and susceptibility to azoles in yeasts
(Prasad et al., 2006; Craven et al., 2007) and the
filamentous fungi A. fumigatus (Zarember et al., 2009)
has been reported. Our results open to a discussion
on the role of iron concentrations in natural habitats
and resistance to azoles that certainly deserves special
attention in future investigations.
Despite its high toxicity, AMB is still used against
IPA (Kousha et al., 1999). Amphotericin B MICs
commonly range between 0.25 and 2 µg/mL (Kazemi et
al., 2013) with resistance breakpoint at MIC >2 µg/mL
(CLSI, 2008). Although results with AMB were lower
in our study (with MIC50 at 0.5 µg/mL), a resistant
strain of A. flavus was detected and other strains
had MICs at breakpoint value (A. flavus and A. terreus).
The high MICs observed in A. terreus to AMB, was
not surprising, since resistance to AMB has already
been reported for this species (Sutton et al., 1999;
Singh & Paterson, 2005). To our knowledge this is
the first report of an AmB-resistant strain of A. flavus
isolated directly from cave sediment. Resistance
to AMB has already been documented for other
Aspergillus species obtained from clinical samples
(Blum et al., 2008; Van Der Linden et al., 2011;
Hadrich et al., 2012).
Interestingly, the resistant strain was collected
from the sediment of an aphotic site covered with
numerous actinomycete colonies. As mentioned by
Khoo et al. (1994), AMB was firstly obtained from
filamentous bacteria (Streptomyces nodosus). It has
been recently reported that other microorganisms
inhabiting extreme environments also produce AMB
as survival mechanism enhancing their ecological
fitness in competing for substrate (Svahn et al., 2015).
Additionally, Seo et al. (1999) induced resistance
to AMB from a wild strain of A. flavus after several
conidial transfers on AMB enriched media. This
could be occurring naturally among wild strains in
the environment. It is plausible to hypothesize that
constant natural exposure to antifungal compounds
produced by competitors (bacteria or fungi) induces
natural selection of drug-resistant strains. Similar
relation has been reported among cave isolated
bacteria (Bhullar et al., 2012). The authors detected
resistance to over fourteen antibiotics by bacteria
isolated from a pristine cave in the United States
and associated resistance with their pan genome and
adaptive response to ecological interactions.
Concerning the investigation of resistance
mechanisms, it has been widely considered that the
main antifungal action of AMB derives from the binding
between ergosterol and AMB altering membrane
permeability and causing leackage of cytoplasmatic
components (Ermishkin et al., 1976; Khoo et al.,
1994; Johnson & Einstein 2007; Laniado-Laborín &
Cabrales-Vargas, 2009). Thus, some authors have
associated the main resistance mechanism to AMB
with decrease of ergosterol content to diminish binding
sites. Others pointed that ergosterol decrease is not
the main resistance mechanism in Aspergillus spp.
(Alcazar-Fuoli et al., 2006; Blum et al., 2008; Alcazar-
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Fuoli & Mellado, 2013) with resistance being more
related with response to oxidative stress (Blum et al.,
2013). Our results showed a substantial ergosterol
increase in the AmB-R strain when exposed to the
agent. It is important to highlight that ergosterol
is involved in several relevant functions in fungi
(e.g., hyphal growth, conidiation, protection) and its
decrease has been classified as a secondary resistance
mechanism (Laniado-Laborín & Cabrales-Vargas,
2009; Mesa-Arango et al., 2014). Furthermore, the
resistant strain showed lower susceptibility to free
radicals, probably due to the overexpression of the
antioxidant system. Our group previously showed that
AMB led to ROS formation and lipid peroxidation in
yeast cells (Cryptococcus gattii) and this phenomenon
strongly increased the enzymatic activities of the
antioxidant system (Ferreira et al., 2013).
The data obtained in the enzymatic assay (PER
and SOD) showed that SOD played major role in
the resistance of A. flavus isolated from RM3 cave.
Fungal AMB-resistance has been related with
enzymatic activity against oxidative stress for
some fungi (Laniado-Laborín & Cabrales-Vargas,
2009; Mesa-Arango et al., 2014). Blum et al. (2008)
showed that AMB-resistance in A. terreus was highly
related with catalase production. Okamoto et al.
(2004) showed that oxidative damage induced by
superoxide was the main activity of AMB against
the yeast C. albicans. In the other hand, it seems
that peroxidases did not play a crucial role in the
resistance mechanism against AMB.
Caving is a common practice that has been
increasing worldwide, causing various impacts on the
subterranean biodiversity (Cigna, 1993; Souza-Silva,
2008; Lobo & Moretti, 2009; Souza-Silva & Ferreira,
2009; Kartalis et al., 2011; Taylor et al., 2013). The
use of ground water and pieces of speleothems for
curative purposes by local population should also
be mentioned (Souza-Silva et al., 2011; Taylor et
al., 2013) especially considering the impacts and
risks posed by this activity. The transport of cave
microorganisms and their contact with individuals of
poor immunologic conditions enhance the chances
of infection by drug-resistant strains. Despite being
important components of cave biodiversity microbial
communities have been poorly investigated in
management plans and monitoring of subterranean
ecosystems (Bhullar et al., 2012; Taylor et al.,
2013; Vanderwolf et al., 2013). In the past decade,
Brazilian governmental agencies have required more
detailed microbiological inventories in caves to reduce
chances of fungal outbreaks. Although the chances
of developing pulmonary fungal infections by other
species than Histoplasma capsulatum while caving are
scarce, these opportunistic infections are emerging
diseases and should be more thoroughly investigated,
as well as their resistance mechanisms. The high
resistance to AMB observed corroborates with the idea
that antibiotic resistance might be a natural event,
resulting from competition among soil organisms and
their metabolites.
In conclusion, our findings broaden the knowledge
concerning the action of AMB against A. flavus and the
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mechanisms of resistance involved. We also speculate
that interactions with environmental conditions (e.g.,
iron concentration) and between organisms lead to an
adaptive response towards natural selection of drug
resistant microorganisms in caves.
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